Gassy .It has been almost a month since final enrolments for trofinetide trial was completed so we probably only have to wait 3 months for the results .From what I have heard from people close to the company is that NNZ2591 is a much better drug with more uses ,much cheaper to produce and has created substantially more interest from potential partners .I would be very nervous if I was Acadia as they have done a lot of the heavy lifting and there is a real risk that someone will make a takeover offer for Neuren and get the gem of NNZ2591 and get the royalties and milestones for trofinetide of over $1 billion dollars.
NEU Price at posting:
$2.19 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)